- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2022-2027
Biomaterials are synthetic or natural materials that are artificially generated and utilised to interact with biological systems for medical reasons and therapies. In medicinal applications, they are frequently employed to supplement or replace a natural function.
They are frequently biodegradable, and some are bio-absorbable, which means they are gradually expelled from the body after performing a role. Metals, ceramics, plastic, glass, and even living cells and tissue can all be utilised to create a biomaterial.
The biomaterial industry is expected to increase dramatically over the coming years as a result of advances in tissue engineering, regenerative medicine, and other fields.
Furthermore, considerable financing from government organisations for product innovation is opening up new opportunities for growth in the biomaterials industry.
The Europe Biomaterials Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
Evonik, a speciality chemical manufacturer, has expanded its biomaterials range with the addition of a new PEEK filament for 3D printed implants. VESTAKEEP iC4800 3DF is an osteoconductive PEEK filament that aids in bone and implant fusion.
The high-performance polymer may be processed using extrusion-based 3D printing technologies such as fused filament fabrication (FFF). At the AAOS trade expo, the new product will be revealed for the first time
The new PEEK filament for 3D printed implants is a biomaterial from Evonik's VESTAKEEP Fusion product family, which was started recently.
The novel high-performance polymer has excellent biocompatibility and biostability, as well as increased osteoconductive characteristics.
To achieve osteoconductivity, biphasic calcium phosphate, a functional special ingredient, was employed (BCP). The BCP addition promotes bone cell adhesion to implants, which improves the bone-implant contact, commonly known as osteointegration. This will speed up bone fusion and thereby patient rehabilitation.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in the Industry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2022-2027 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2022-2027 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2022-2027 |
| 21 | Product installation rate by OEM, 2022 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2022 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.